Open access
Sep 2026
Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity.
<jats:p/>
Tony Yao, Rita E. Chen, Melissa M. Yamada et al.
· Journal of Clinical Investig... · 0 citations